Skip to main content
. 2011 Mar 1;11(1):1–8. doi: 10.1102/1470-7330.2011.0001

Figure 1.

Figure 1

[99mTc]Sestamibi images of breast cancer obtained 20 min (early) and 120 min (late) after injection of radiotracer. (A) A patient with tumour displaying immunohistochemically negative P-gp expression showing tumour/background (T/B) that increased from 1.65 to 1.99. (B) A patient with tumour displaying strongly positive P-gp expression showing T/B that decreased from 2.25 to 1.52. Reprinted by permission of the Society of Nuclear Medicine from Mubashar M, Harrington KJ, Chaudhary KS, et al. 99mTc-Sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer. J Nucl Med 2002; 43: 519–25, Figure 2).